Jain PharmaBiotech, May 2012, Pages: 1037
for infections but are now increasing in the areas of genetic disorders, preimplantation screening and cancer. Genetic screening tests, despite some restrictions is a promising area for future expansion
Global Industry Analysts, Inc., Sep 2010, Pages: 546
Food Safety Testing - Global Strategic Business Report This report analyzes the worldwide markets for Food Safety Testing in US$ Million by the following product segments - Pathogens Testing
Global Industry Analysts, Inc., Oct 2010, Pages: 659
Molecular Diagnostics - Global Strategic Business Report This report analyzes the worldwide markets for Molecular Diagnostics in US$ million by the following segments: Infectious Disease Testing
Takeda Pacific, Feb 2010, Pages: 144
Biomarkers, Tests and Trends for Drug R&D This report is about the world market for biomarkers and tests used for drug R&D. The study reviews and analyzes the market by examining biomarker related
Global Markets Direct, Dec 2008, Pages: 114
, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions
Global Markets Direct, Dec 2008, Pages: 111
, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions
Global Markets Direct, Dec 2008, Pages: 142
, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions
Global Markets Direct, Dec 2008, Pages: 112
, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions
Global Markets Direct, Feb 2009, Pages: 145
, approval process, pricing trends and reimbursement.
-Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
-Key mergers and acquisitions
Informa Healthcare, Jan 2007, Pages: 250
to be developed for applications in areas such as oncology, cardiovascular disease, pharmacogenetics, and genetic disease testing.
Key segments of the IVD market
This report analyses key segments of the clinical
Global Markets Direct, Dec 2008, Pages: 144
Hepatitis C Test 138
33.1.2 Aug 19, 2008: QIAGEN Unveils Diagnostic Assay in the EU to Detect Genetic Variation Causing Adverse Reactions In AIDS Patients 138
34 Appendix 139
34.1 Global Markets Direct
Global Markets Direct, Dec 2008, Pages: 132
, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions
Global Markets Direct, Nov 2008, Pages: 111
, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions
Global Markets Direct, Dec 2009, Pages: 164
Reagents, GeneticTest Reagents, Self Testing, and Instruments.
- Market shares of all the key competitors including F. Hoffmann-La Roche Ltd., Abbott Laboratories, Beckman Coulter, Inc., and Siemens
Global Markets Direct, Sep 2009, Pages: 151
, Microbiology Test Reagents, Infectious Immunology, Test Reagents, GeneticTest Reagents, Self Testing, and Instruments.
- Total revenues, end users
- Market shares of all the key competitors.
- Key pipeline
